Drug profile · INN
avalglucosidase alfa-ngpt
NEXVIAZYME
avalglucosidase alfa-ngpt (NEXVIAZYME) is a glycogen hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Drug details — avalglucosidase alfa-ngpt
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
avalglucosidase alfa-ngpt (NEXVIAZYME) is a glycogen hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Glycogen hydrolytic enzyme
Primary target: Glycogen
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Congress & event coverage
Related & competitor drugs
Frequently asked questions
What is avalglucosidase alfa-ngpt?
avalglucosidase alfa-ngpt (NEXVIAZYME) is a glycogen hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for avalglucosidase alfa-ngpt?
NEXVIAZYME is a marketed brand name for avalglucosidase alfa-ngpt. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of avalglucosidase alfa-ngpt?
avalglucosidase alfa-ngpt has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.